Hypertension Specialist
Core curriculum
Section 8: How to treat lifestyle modifications
a. Cessation of smoking
http://www.eshonline.org/education/newsletter.htm
High Blood Pressure, Smoking and Cardiovascular Risk; (H. Pardell, J.L. Rodicio)
Newsletter no 20
b. Body weight reduction
c. Increased physical activity
http://www.eshonline.org/education/newsletter.htm
Exercise and Hypertension;Athanasios J. Anolis
Newsletter no 23
d. Reduction of sodium intake
WEBCASTS: Parallel Oral Session, 15 June 2006
Dietary approach for BP management - An update; Peter De Leeuw, NL
http://www.eshonline.org/education/congresses/2006/esh/15_giu_POS_4.asp
e. Increased potassium intake
f. Reduction of alcohol intake
http://www.eshonline.org/education/newsletter.htm
High Blood Pressure, Alcohol and Cardiovascular Risk; (R. Estruch, A. Coca, J.L. Rodicio
Newsletter no 22
g. Calcium and magnesium
h. Other dietary interventions
i. Lifestyle modifications and global cardiovascular risk
j. Lifestyle modifications and compliance to treatment
Section 9: Drug treatment
a. Designs and requirements for studies on antihypertensive drugs
b. Pharmacokinetics of antihypertensive drugs
c. Pharmacodynamics of antihypertensive drugs
d. Drug interactions
e. Antihypertensive drug classes
I. Historical notes
II. Diuretics:
- Thiazides
- Loop diuretics
- Potassium sparing diuretics
III. Sympatholitics:
- Central agents
http://www.eshonline.org/education/archivio/lectures/clement.htm
D.L. Clement (Ghent, Belgium, Centrally Acting Drugs
- Alfa-blockers
- Beta-blockers
- Alfa/Beta blockers
IV. Calcium channel blockers:
- Dihydropiridines
- Phenylalkilamines
V. Angiotensin converting enzyme inhibitors
VI. Angiotensin receptor antagonists
VII. Vasopeptidase inhibitors
VIII. Endothelin antagonists
Topical Workshop 7: Endothelins in Hypertension and Cardiovascular Disease; 14 June 2006
http://www.eshonline.org/education/congresses/2006/esh/14_giu_art7.asp
IX. Other vasodilators
X. Hybrids
XI. Perspectives
http://www.eshonline.org/education/congresses/2006/esh/teaching_seminars.asp#javascript();
Thursday, June 15 Teaching Seminar 10; 2006
T. Unger, DE; Interventions of new mechanisms
f. Therapeutic strategies
WEBCASTS: Plenary Session – Auditorium, 15 June 2006
New-onset diabetes and antihypertensive drugs; G. Mancia, IT
http://www.eshonline.org/education/congresses/2006/esh/15_giu_PS_AU.asp
I. Principles guiding choice of initial drug
II. Principles guiding drug combinations
Seminars 2001;
http://www.eshonline.org/education/archivio/lectures/zweiten.htm
P.A. van Zwieten (Amsterdam, The Netherlands); How to use Diuretics, Beta- blockers, Calcium Antagonists and Combination Therapy?
http://www.eshonline.org/education/newsletter.htm
Beneficial Combinations of Two or More Antihypertensive Agents; P. A. van Zwieten, C. Farsang)
Newsletter no 18
III. Step-care approach
IV. Sequential monotherapy
V. Combination treatment as first choice
VI. Fixed combinations. Advantages/disadvantages
VII. Preferential and compelling drug choices
http://www.eshonline.org/education/archivio/esh2003/teaching_seminars_2003.htm
16 June, 2004, D. van Zwieten, Controversies in anty_HT treatement.
VIII. Treatment maintenance and duration
IX. Strategies for improving compliance to treatment
http://www.eshonline.org/education/congresses/esh_2005/teaching_seminars.asp
Monday, June 20, 2005
How to improve compliance to antihypertensive therapy Prof. X. Girerd
http://www.eshonline.org/education/newsletter.htm
Patient Compliance in the Treatment of Arterial Hypertension; (J.-M. Mallion, D. Schmitt)
Newsletter no 8
X. Assessment of adverse effects
http://www.eshonline.org/education/newsletter.htm
Interactions between Antihypertensive Agents and Other Drugs; P. A. van Zwieten, C. Farsang)
Newsletter no 18
XI. Associated antiaggregant and lipid lowering treatments
Teaching Session Wednesday, June 26
http://www.eshonline.org/education/archivio/esh2002/webcourse.htm;
INTERACTION BETWEEN ANTIHYPERTENSIVE AND OTHER DRUGS; van Zwieten P
Section 10: Resistant hypertension
http://www.eshonline.org/education/congresses/esh_2005/teaching_seminars.asp
Saturday, June 18; 2005
Resistant hypertension: definition and management; Prof. S. Erdine
B. Waeber (Lausanne, Switzerland; Resistant Hypertension
http://www.eshonline.org/education/archivio/lectures/waeber.htm
http://www.eshonline.org/education/newsletter.htm
Resistant Hypertension; (S. Erdine)
Newsletter no 15
a. Definition
b. Prevalence
c. Causes
d. Management
Section 11: Hypertensive emergencies
http://www.eshonline.org/education/archivio/esh2002/webcourse.htm
HYPERTENSIVE CRISIS; Farsang C
http://www.eshonline.org/education/newsletter.htm
Treatment of hypertensive urgencies and emergencies; Enrico Agabiti Rosein
Newsletter No. 28
|
